Sign in
Stories
Ophthalmic Drugs Contract Manufacturing Market Growth
Share
Biopharmaceutical Companies Merge and Pr...
Biopharmaceutical Merger and Presentatio...
Eyewear Evolution: Trends & Markets
AscellaHealth Forecasts Robust Outlook f...
Corneal Implants Market Growth Projectio...
Corneal Implants Market Growth Trends
Overview
API
The ophthalmic drugs contract manufacturing market is driven by the rising prevalence of ophthalmic disorders, outsourcing manufacturing to contract development and manufacturing organizations (CDMOs) for cost efficiency, and technological innovations. The market is projected to grow at a CAGR of 6.4% during the forecast period 2023-2033, with major players including Lonza, Recipharm, Catalent Inc., Eurofins Scientific, and Thermo Fisher Scientific Inc.
Ask a question
How are CDMOs addressing the complex regulatory framework in the ophthalmic drug contract manufacturing industry?
How are technological innovations in ophthalmic devices reshaping the market and creating new opportunities?
What are the potential implications of the increasing prevalence of ophthalmic disorders on the demand for ophthalmic drugs contract manufacturing services?
Article Frequency
0.2
0.4
0.6
0.8
1.0
May 2023
Jun 2023
Jul 2023
Aug 2023
Coverage